113 related articles for article (PubMed ID: 3720569)
1. The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review.
Grimm RH
Drugs; 1986; 31 Suppl 1():13-21. PubMed ID: 3720569
[TBL] [Abstract][Full Text] [Related]
2. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
[TBL] [Abstract][Full Text] [Related]
3. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.
Rautaharju PM; Neaton JD
Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700
[TBL] [Abstract][Full Text] [Related]
5. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
[TBL] [Abstract][Full Text] [Related]
6. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
[TBL] [Abstract][Full Text] [Related]
7. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.
Circulation; 1984 Dec; 70(6):996-1003. PubMed ID: 6388901
[TBL] [Abstract][Full Text] [Related]
8. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
JAMA; 1982 Sep; 248(12):1465-77. PubMed ID: 7050440
[TBL] [Abstract][Full Text] [Related]
9. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
[TBL] [Abstract][Full Text] [Related]
10. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.
JAMA; 1990 Apr; 263(13):1795-801. PubMed ID: 2179590
[TBL] [Abstract][Full Text] [Related]
11. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.
Lasser NL; Grandits G; Caggiula AW; Cutler JA; Grimm RH; Kuller LH; Sherwin RW; Stamler J
Am J Med; 1984 Feb; 76(2A):52-66. PubMed ID: 6367451
[TBL] [Abstract][Full Text] [Related]
12. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
13. Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.
Holme I; Helgeland A; Hjermann I; Leren P; Lund-Larsen PG
JAMA; 1984 Mar; 251(10):1298-9. PubMed ID: 6366258
[TBL] [Abstract][Full Text] [Related]
14. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
[TBL] [Abstract][Full Text] [Related]
15. Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial.
Connett JE; Stamler J
Am Heart J; 1984 Sep; 108(3 Pt 2):839-48. PubMed ID: 6475754
[TBL] [Abstract][Full Text] [Related]
16. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.
Yudkin JS
BMJ; 1993 May; 306(6888):1313-8. PubMed ID: 8518573
[TBL] [Abstract][Full Text] [Related]
17. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
Circulation; 1996 Sep; 94(5):946-51. PubMed ID: 8790030
[TBL] [Abstract][Full Text] [Related]
18. Brief description of the Multiple Risk Factor Intervention Trial.
Kjelsberg MO; Cutler JA; Dolecek TA
Am J Clin Nutr; 1997 Jan; 65(1 Suppl):191S-195S. PubMed ID: 8988937
[TBL] [Abstract][Full Text] [Related]
19. Influence of treatment of "mild" hypertension on coronary heart disease.
Stamler R
Acta Med Scand Suppl; 1985; 701():89-99. PubMed ID: 3907299
[TBL] [Abstract][Full Text] [Related]
20. Further analyses of the hypertension detection and follow-up program.
Langford HG
Drugs; 1986; 31 Suppl 1():23-8. PubMed ID: 2941267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
